Pediatric cancer recurrence poses a significant challenge in the journey of healing for young patients, particularly those with gliomas, a type of brain tumor.Recent advancements in AI in pediatric oncology are proving to be game-changers, enhancing the accuracy of predicting cancer relapse over traditional methods.